Mednet Logo
HomeRadiation Oncology
Radiation Oncology

Radiation Oncology

Expert insights on radiation treatment planning, techniques, toxicity management, and multimodal cancer care.

Recent Discussions

What is the appropriate dose of radiation for a primary osseous non-Hodgkin's lymphoma?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Hospital of the University of Pennsylvania

Acceptable doses range from 30 Gy to 45 Gy. Would consider 30 Gy if there is a metabolic complete response after 2 cycles of R-CHOP and the patient got at least 4 cycles total. 45 Gy is the dose used in the prospective TROG trial of bony DLBCL, so it has some data behind it. In the femur, the bigges...

Would you give pentoxiphylline and vitamin E during HBO for vaginal necrosis?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Virginia Commonwealth University Medical Center

My usual approach to treating radiation injuries in the pelvis would be to start with Vitamin E (Vit E) and pentoxifylline (PTX) for less severe radiation-related injuries, but in cases with ulceration and/or necrosis or bleeding requiring transfusion to proceed directly to hyperbaric oxygen (HBO). ...

How do you instruct patients taking sucralfate?

1
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Yale School of Medicine

I have been prescribing carafate for many years now and to this day I don't know if it helps patients or if compliance is possible. I would be curious to know what the experts think.

Are there any contraindications to treating early stage breast cancer with radiation in patients on rituximab?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

I have treated patients with RT and retuximab with no increased acute morbidity whether efficacy would be compromised is not known

How would you approach treatment of a brainstem AVM after hemorrhage in a patient not a candidate for surgery or embolization?

2 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Louisville School of Medicine

The question posted is a challenging one.First of all, one has to wait, after a bleed, for all the blood products to disappear before an angiogram to have a good idea of the nidus in terms of location within the brain stem, size, and geometry. The patient’s neurological status after a bleed in the b...

If a PET/CT scan is positive for mediastinal lymph node involvement, is a mediastinoscopy or EBUS still required for NSCLC staging?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

The gold standard for mediastinal staging is still mediastinoscopy. You can have 15 to 20 percent false positive PET findings in mediastinum and for these patients surgery should not be excluded based on PET findings alone.

How would you approach a subcutaneous oligometastatic uterine carcinosarcoma?

2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

Systemic treatment. For local, based on response to systemic, can consider local excision or hypofractionation with a schedule like skin cancer.

What is the age cut-off to omit radiation therapy after breast conserving surgery for early stage breast cancer?

10
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · Northwestern University

I agree with the above answers and would like to expand a bit. What is so special about being over 70 (or over 65 for that matter) when your breast cancer is diagnosed? Not much. Age is a rough surrogate for life expentancy and perhaps also for biologic subtype. But we have SEVERAL trials across bro...

What follow-up imaging do you recommend after SBRT/SABR for lung cancer?

4
4 Answers

Mednet Member
Mednet Member
Radiation Oncology · Duke University Medical Center

I generally take a more conservative approach for follow-up. Most guidelines do not recommend, in fact they discourage, routine PET-CT after definitive treatment of lung cancer. Therefore, for pure surveillance purposes I utilize chest CT only. My schedule is every 6 months for 2 years and annually ...

How does the recent publication of RTOG 0813 affect your management of centrally located lung tumors?

6
4 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Pennsylvania Health System

RTOG 0813 s a very valuable data set. This was the first trial using the TITER method performed within NRG Oncology (formerly RTOG). When 0813 was written, we fully expected there to be more toxicity events than were actually experienced. Please remember that we did not limit dose to central structu...